Post-effective amendment to a registration statement that is not immediately effective upon filing

Segment Reporting (Details) - Schedule of segment reporting information, by segment

v3.23.1
Segment Reporting (Details) - Schedule of segment reporting information, by segment - Operating Segments [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Net Revenue:    
Total Net Sales $ 17,800 $ 15,374
Segment Profit (Loss):    
Gross profit (62,374) (14,284)
Reconciliation:    
Total Segment Loss (62,374) (14,284)
Unallocated corporate expenses (8,327) (11,196)
Non-cash share based compensation (2,343) (11,451)
Depreciation and amortization (2,058) (1,768)
Goodwill impairment (18,508)
Loss from operations (75,102) (57,207)
(Gain) loss on debt extinguishment, net 2,263 (3,262)
Gain on remeasurement of warrant liability (2,092) (16,856)
Loss on investments (6,851)
Foreign exchange loss 1,129 1,276
Interest expense 2,702 6,818
Other income, net 202 (502)
Loss from operations before income taxes and equity investment loss (72,455) (44,681)
Long-lived assets    
Long-lived assets 15,463 30,932
Cannabinoid [Member]    
Segment Net Revenue:    
Total Net Sales 6,119 3,242
Segment Profit (Loss):    
Gross profit (63,720) (16,915)
Long-lived assets    
Long-lived assets 15,308 30,709
Non-Cannabinoid [Member]    
Segment Net Revenue:    
Total Net Sales 11,681 12,132
Segment Profit (Loss):    
Gross profit 1,346 2,631
Long-lived assets    
Long-lived assets 155 216
Other [Member]    
Long-lived assets    
Long-lived assets $ 7